FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to indolyl-substituted derivatives of thiadiazinones prepared from oxamic acid thiohydrazide of general formula: , wherein R represents H; R1 represents pyridinyl; phenyl substituted by alkyl C1-C5, Hal, CF3; R2 represents H; alkyl C1-C5; -CH2COOR4; benzyl substituted by Hal, OR4; benzoyl substituted by Hal, OR4, while R4 represents unsubstituted alkyl C1-C4.
EFFECT: there are prepared new compound which can find application in medicine for developing the therapeutic agent possessing pathogenic bacteria inhibitory activity.
2 cl, 2 dwg, 2 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
PATHOGENIC BACTERIA-INHIBITING BIOLOGICALLY ACTIVE SUBSTANCES AND METHOD OF INHIBITING PATHOGENIC BACTERIA TYPE III SECRETION | 2010 |
|
RU2447066C2 |
PATHOGENIC BACTERIA INHIBITING BIOLOGICALLY ACTIVE SUBSTANCES | 2008 |
|
RU2402531C2 |
N-SUBSTITUTED DERIVATIVES OF OXAMIC ACID THIOHYDRAZIDES, SYNTHESIS METHOD AND USE THEREOF | 2009 |
|
RU2400471C1 |
SELECTIVE ANTI-TUBERCULOSIS AGENTS, REPRESENTING 3-AMINOSUBSTITUTED 6-(3,5-DIMETHYLPYRAZOL-1-YL)-1,2,4,5-TETRAZINES | 2012 |
|
RU2519218C2 |
SUBSTITUTED SPIRO ANDROSTENES-17, 6'[1,3,4]THIADIAZINES WITH ANTIVIRAL ACTIVITY | 2021 |
|
RU2750639C1 |
2-AMINO-SUBSTITUTED 6-METHOXY-4-TRIFLUOROMETHYL-9H-PYRIMIDO[4,5B]INDOLES, METHOD FOR THEIR PRODUCTION, APPLICATION AND PREDIMINARIES | 2016 |
|
RU2625316C1 |
COMPOUNDS FOR TREATING CANCER | 2010 |
|
RU2581367C2 |
3-TRIAZENONE INDOLES POSSESSING MYCOBACTERIUM ACTIVITY | 2016 |
|
RU2724334C1 |
TRIALLILBORANE ADDUCTS WITH AMMONIA AND AMINES AS ALLYLATING REAGENTS | 2018 |
|
RU2678208C1 |
2-HETARYL-SUBSTITUTED OF 1,3-TROPOLONE, METHOD FOR THEIR PREPARING (VARIANTS) AND PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL EFFECT | 2006 |
|
RU2314295C2 |
Authors
Dates
2013-10-10—Published
2012-05-05—Filed